New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries

Tejeshwar Jain, Prateek Sharma, Abhi C. Are, Selwyn M. Vickers, Vikas Dudeja

Research output: Contribution to journalReview articlepeer-review

Abstract

The past decade has witnessed groundbreaking advances in the field of microbiome research. An area where immense implications of the microbiome have been demonstrated is tumor biology. The microbiome affects tumor initiation and progression through direct effects on the tumor cells and indirectly through manipulation of the immune system. It can also determine response to cancer therapies and predict disease progression and survival. Modulation of the microbiome can be harnessed to potentiate the efficacy of immunotherapies and decrease their toxicity. In this review, we comprehensively dissect recent evidence regarding the interaction of the microbiome and anti-tumor immune machinery and outline the critical questions which need to be addressed as we further explore this dynamic colloquy.

Original languageEnglish (US)
Article number622064
JournalFrontiers in immunology
Volume12
DOIs
StatePublished - Feb 23 2021
Externally publishedYes

Keywords

  • cancer
  • cancer immunotherapy
  • gut microbiome
  • immune system
  • microbiome-immune crosstalk
  • tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries'. Together they form a unique fingerprint.

Cite this